Release details

Pacira BioSciences Joins Life Science Cares as National Corporate Partner

July 06, 2026

-- Collaboration expands community impact across the San Francisco Bay Area, San Diego, and New Jersey --

SAN FRANCISCO, July 6, 2026 - Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced it has joined Life Science Cares (LSC) as a National Corporate Partner. Through this multi-region partnership, Pacira will provide financial support and employee volunteer engagement to help address poverty and inequality across three major life science hubs: the San Francisco Bay Area, San Diego, and New York/New Jersey.

By aligning with Life Science Cares, Pacira joins a collective effort within the life sciences sector to support high-impact nonprofits providing access to basic needs, education, and economic opportunity.

“At Pacira, we believe that true leadership in healthcare extends far beyond the treatments we develop; it requires a deep commitment to the health and well-being of the communities we serve,” said Kristen Williams, Chief Administrative Officer & Secretary at Pacira BioSciences. “Joining Life Science Cares as a national partner allows our team to turn our passion into purpose, actively breaking down systemic barriers and building brighter, more sustainable futures alongside our industry peers.”

“Partnerships like this are the heart of our mission,” said Sarah MacDonald, Life Science Cares CEO. “We are excited to partner with Pacira and showcase how mobilizing resources and people power for those who need it most can have a tremendous impact. Together, we are proving that the life sciences industry can play a powerful role in breaking the cycle of poverty and creating real, lasting change.”

The collaboration between Pacira and Life Science Cares showcases how corporate social responsibility and employee engagement can drive local impact. Beyond corporate funding, Pacira employees will engage in hands-on volunteerism designed to bridge the opportunity gap for underrepresented populations.

Life Science Cares Impact at a Glance

Over the last decade, thanks to partnerships with forward-thinking companies like Pacira, Life Science Cares has built a robust legacy of systemic support:

  • Invested over $26M in high-impact nonprofits
  • Engaged over 31K+ volunteers from across the industry
  • Dedicated nearly 80K+ hours to volunteering
  • Placed more than 1,300+ low-income undergraduate students in paid summer internships in the industry across 345 companies

About Pacira Biosciences

Pacira delivers innovative, non-opioid pain therapies to transform the lives of patients. Pacira has three commercial-stage non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting local analgesic currently approved for infiltration, fascial plane block, and as an interscalene brachial plexus nerve block, an adductor canal nerve block, and a sciatic nerve block in the popliteal fossa for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular injection indicated for the management of osteoarthritis knee pain; and iovera®°, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. The company is also advancing a pipeline of clinical-stage assets for musculoskeletal pain and adjacencies, its most advanced product candidate, PCRX-201 (enekinragene inzadenovec), a novel locally administered gene therapy, is in Phase 2 clinical development for osteoarthritis of the knee. To learn more about Pacira, visit www.pacira.com.

About Life Science Cares

Life Science Cares (LSC) activates the financial and human capital of the life sciences industry and partners with nonprofits to disrupt the cycle of poverty and inequality in our communities. Now operating in five US life science hubs (Boston, Philadelphia, San Diego, the San Francisco Bay Area, and New York) as well as Switzerland, LSC has invested $26 million and engaged over 30,000 volunteers in the industry in community organizations providing access to basic needs, access to education, or access to opportunity. To learn more about Life Science Cares, visit https://lifesciencecares.org/.